sponsored links

Pharmacyclics’ blood cancer drug responses rise (Reuters)

Sponsored Links

Reuters – Interim results from an early stage trial of Pharmacyclics Inc’s experimental blood cancer drug show the number of leukemia patients responding to the medicine has increased over time.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.